2026年,联邦资金削减干扰了儿科脑癌研究,延误了治疗罕见儿童疾病的进展。 Federal funding cuts are disrupting pediatric brain cancer research in 2026, delaying progress on treatments for a rare childhood disease.

据UMass Chan医学院的Rachael Sirianni博士说,2026年,2025年底开始的联邦资金削减继续扰乱了儿科脑癌研究。 Federal funding cuts that began in late 2025 continue to disrupt pediatric brain cancer research in 2026, according to Dr. Rachael Sirianni of UMass Chan Medical School. 支助的减少推迟了实验,阻碍了人员配置和设备维护,破坏了长期规划。 Reduced support has delayed experiments, hindered staffing and equipment maintenance, and undermined long-term planning. 不确定性正在威胁发展治疗罕见和致命儿童疾病的进展,凸显了在维持联邦对罕见疾病研究的投资方面的更广泛挑战。 The uncertainty is threatening progress in developing treatments for a rare and deadly childhood disease, highlighting broader challenges in sustaining federal investment in rare disease research.